Deal of the Day — limited-time pharmacy picks!
Tafero - EM

Tafero - EM

Prescription requiredRx Required

Salt Composition: Emtricitabine and Tenofovir Alafenamide

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

30 tablets

About The Product

HIV Infection

Tafero EM is a generic medication containing emtricitabine and tenofovir alafenamide and is intended for use in adults and adolescents above 12 years old with a body weight equal to or greater than 35 kilograms. Tafero EM is administered orally on a daily basis, with or without food, and acts as a reverse transcriptase inhibitor, thereby preventing replication of HIV‑1.

Not only does Tafero EM prevent the spread of infection along with other antiretroviral medicines, but it may also be used as a form of PrEP (pre‑exposure prophylaxis) for those individuals who have an increased risk of being infected. Although not a cure for HIV, Tafero EM provides effective control and enhances the immune response of an individual.

Uses

HIV infection treatment

Side Effects

The following are the possible side effects that can occur during your treatment with Tafero-EM. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.

  • Nausea and vomiting
  • Diarrhea
  • Headache
  • Fatigue
  • Insomnia (difficulty sleeping)
  • Fever and cough
  • Liver function abnormalities
  • Allergic reactions
  • Reactivation of Hepatitis B
  • Increased risk of bone fractures
  • Acute kidney failure

Dosage and Administration

  • The recommended dose of Tafero EM medicine is decided by a doctor according to your previous medical condition and response to the treatment.
  • Do not take this medicine in the wrong way, as it may lead to some serious side effects.
  • Take the tablet at the same time each day, with food, and swallow it whole with water; do not split, chew, or crush it.

Mechanism of action

Emtricitabine (Tafero EM), a synthetic nucleoside analog of cytidine, is phosphorylated by cellular enzymes to form emtricitabine 5'-triphosphate.

Emtricitabine inhibits the activity of the HIV-1 reverse transcriptase (RT) by competing with the natural substrate deoxycytidine 5'-triphosphate and by being incorporated into nascent viral DNA, which results in chain termination.

Safety Advice

Alcohol
Do not consume alcohol while taking Tafero-EM.
Pregnancy
Do not take Tafero-EM without consulting the doctor, in case of pregnancy.
Breast Feeding
Do not take Tafero-EM if you're breastfeeding; it can cause harm to the newborn. Consultation of the doctor is advised.
Driving
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of Tafero-EM.
Kidney
Do not take Tafero-EM without a doctor's consultation in case of kidney problems.
Liver
Share your medical history with the doctor in case of liver disease before taking Tafero-EM.

Missed Doses

  • If you miss a dose of Tafero EM take it as soon as you remember.
  • If it’s nearly time for your next scheduled dose, skip the missed one and continue with your regular routine.
  • Do not take two tablets at once to make up for the missed dose.

FAQs

Tafero EM tablet is an antiviral medication that prevents the human immunodeficiency virus (HIV) from multiplying in your body.

It also helps to delay the progression of HIV infection and improves the quality of life

References

  • Ali, S. H., Shah, M. H., Roy, S., Bharadwaj, H. R., Tan, J. K., Rao, M. S., Dalal, P. (2025). Efficacy and safety of tenofovir plus entecavir combination therapy versus tenofovir monotherapy in chronic hepatitis B virus patients with resistance or partial response to entecavir. Journal of Clinical and Experimental Hepatology, 15(4), 102541. PubMed+1PubMed+1 - https://pubmed.ncbi.nlm.nih.gov/40248347/
  • Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis. (2025). Frontiers in Pharmacology, 16, 1507117. PMC+1PubMed+1 - https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1507117/full
  • Tenofovir alafenamide fumarate, tenofovir disoproxil fumarate, and entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta‑analysis. (2025). Journal of Viral Hepatitis & Hepatology.

Certified Content

Written By
Venika Choudhary

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By
Dr. Aditya Sarin

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026